Alain Sureau

885 total citations
16 papers, 727 citations indexed

About

Alain Sureau is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Alain Sureau has authored 16 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 2 papers in Cellular and Molecular Neuroscience and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Alain Sureau's work include RNA Research and Splicing (12 papers), RNA modifications and cancer (6 papers) and RNA and protein synthesis mechanisms (6 papers). Alain Sureau is often cited by papers focused on RNA Research and Splicing (12 papers), RNA modifications and cancer (6 papers) and RNA and protein synthesis mechanisms (6 papers). Alain Sureau collaborates with scholars based in France, Germany and United Kingdom. Alain Sureau's co-authors include Bernard Perbal, Joëlle Marie, Alain Expert-Bezancon, J. Soret, Jérôme Saulière, Michel Vellard, C. Martinerie, Roland Salesse, Denis Furling and Arnaud F. Klein and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Alain Sureau

16 papers receiving 720 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alain Sureau France 12 673 69 65 44 38 16 727
Johanne Toutant Canada 15 834 1.2× 38 0.6× 96 1.5× 55 1.3× 22 0.6× 18 916
Natalya Benderska Germany 12 479 0.7× 20 0.3× 109 1.7× 24 0.5× 38 1.0× 13 553
Michael A. Cortázar United States 10 832 1.2× 19 0.3× 62 1.0× 33 0.8× 56 1.5× 12 896
Lawrence Rothblum United States 10 789 1.2× 24 0.3× 37 0.6× 43 1.0× 72 1.9× 13 862
Jayanthi Gudikote United States 11 454 0.7× 26 0.4× 48 0.7× 32 0.7× 24 0.6× 15 531
Jacki Heraud-Farlow Australia 12 583 0.9× 25 0.4× 77 1.2× 159 3.6× 21 0.6× 17 645
Caroline Dalgliesh United Kingdom 18 825 1.2× 30 0.4× 188 2.9× 43 1.0× 96 2.5× 23 970
Miriam Di Re United Kingdom 9 641 1.0× 30 0.4× 26 0.4× 33 0.8× 26 0.7× 9 706
Bernd Rattenbacher United States 7 480 0.7× 44 0.6× 106 1.6× 101 2.3× 25 0.7× 7 563
Johann Soret France 16 758 1.1× 25 0.4× 92 1.4× 19 0.4× 82 2.2× 24 871

Countries citing papers authored by Alain Sureau

Since Specialization
Citations

This map shows the geographic impact of Alain Sureau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Sureau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Sureau more than expected).

Fields of papers citing papers by Alain Sureau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alain Sureau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Sureau. The network helps show where Alain Sureau may publish in the future.

Co-authorship network of co-authors of Alain Sureau

This figure shows the co-authorship network connecting the top 25 collaborators of Alain Sureau. A scholar is included among the top collaborators of Alain Sureau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alain Sureau. Alain Sureau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Arandel, Ludovic, Arnaud F. Klein, Frédérique Rau, et al.. (2022). Reversal of RNA toxicity in myotonic dystrophy via a decoy RNA-binding protein with high affinity for expanded CUG repeats. Nature Biomedical Engineering. 6(2). 207–220. 25 indexed citations
2.
Hubé, Florent, Damien Ulveling, Alain Sureau, Sabrina Forveille, & Claire Francastel. (2016). Short intron-derived ncRNAs. Nucleic Acids Research. 45(8). gkw1341–gkw1341. 23 indexed citations
3.
Laurent, François-Xavier, et al.. (2011). New function for the RNA helicase p68/DDX5 as a modifier of MBNL1 activity on expanded CUG repeats. Nucleic Acids Research. 40(7). 3159–3171. 61 indexed citations
4.
Sureau, Alain, Jérôme Saulière, Alain Expert-Bezancon, & Joëlle Marie. (2010). CELF and PTB proteins modulate the inclusion of the β-tropomyosin exon 6B during myogenic differentiation. Experimental Cell Research. 317(1). 94–106. 12 indexed citations
5.
Saulière, Jérôme, Alain Sureau, Alain Expert-Bezancon, & Joëlle Marie. (2006). The Polypyrimidine Tract Binding Protein (PTB) Represses Splicing of Exon 6B from the β-Tropomyosin Pre-mRNA by Directly Interfering with the Binding of the U2AF65 Subunit. Molecular and Cellular Biology. 26(23). 8755–8769. 75 indexed citations
6.
Expert-Bezancon, Alain, et al.. (2004). hnRNP A1 and the SR Proteins ASF/SF2 and SC35 Have Antagonistic Functions in Splicing of β-Tropomyosin Exon 6B. Journal of Biological Chemistry. 279(37). 38249–38259. 69 indexed citations
7.
Sureau, Alain. (2001). SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs. The EMBO Journal. 20(7). 1785–1796. 256 indexed citations
8.
Soret, Johann, Renata Gattoni, Alain Sureau, et al.. (1998). Characterization of SRp46, a Novel Human SR Splicing Factor Encoded by a PR264/SC35 Retropseudogene. Molecular and Cellular Biology. 18(8). 4924–4934. 29 indexed citations
9.
Sureau, Alain. (1997). Characterization of multiple alternative RNAs resulting from antisense transcription of the PR264/SC35 splicing factor gene. Nucleic Acids Research. 25(22). 4513–4522. 26 indexed citations
10.
Sureau, Alain & Bernard Perbal. (1994). Several mRNAs with variable 3' untranslated regions and different stability encode the human PR264/SC35 splicing factor.. Proceedings of the National Academy of Sciences. 91(3). 932–936. 33 indexed citations
11.
Seneca, Sara, et al.. (1993). The carboxy-terminal domain of c-Myb activates reporter gene expression in yeast.. PubMed. 8(9). 2335–42. 6 indexed citations
12.
Vellard, Michel, Alain Sureau, J. Soret, C. Martinerie, & Bernard Perbal. (1992). A potential splicing factor is encoded by the opposite strand of the trans-spliced c-myb exon.. Proceedings of the National Academy of Sciences. 89(7). 2511–2515. 77 indexed citations
13.
Sureau, Alain, J. Soret, Michel Vellard, J Crochet, & Bernard Perbal. (1992). The PR264/c-myb connection: expression of a splicing factor modulated by a nuclear protooncogene.. Proceedings of the National Academy of Sciences. 89(24). 11683–11687. 22 indexed citations
14.
Merzak, Abderrahim, J. Soret, C. Martinerie, et al.. (1992). Transforming potential of truncated v-myb and stimulation of replication by gag-myb fusion products.. PubMed. 7(3). 535–42. 3 indexed citations
15.
Vellard, Michel, J. Soret, Alain Sureau, & Bernard Perbal. (1991). A novel type of RNA-binding protein is potentially encoded by the opposite strand of the trans-spliced c-myb coding exon.. PubMed. 313(13). 591–7. 6 indexed citations
16.
Sureau, Alain & Bernard Perbal. (1991). Intermolecular recombination of human c-myb proto-oncogene coding sequences.. PubMed. 312(7). 323–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026